CD8A and breast cancer: Indeed, in the MMTV-PyMT mammary tumor model, TAM-derived IL10 indirectly blocks anti-tumor CD8+ T cell activity by suppressing IL12 expression by intratumoral DCs upon paclitaxel treatment (149).